Man I thought the negative shorts here would be some what smarter than the ones on the penny stock boards, lol clearly that's not the case after reading some of these posts haha. This stock hasn't been under $2 for almost the entire year, and has never ever been anywhere near these prices in the history of this company. The value of this company had almost nothing to do with this product, and everything to do with the products already on the markets and the future cancer drugs in development that are showing great promise in late stage trails.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.